BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4554634)

  • 1. The effect of lidoflazine on the exercise capacity of normal volunteers: double-blind cycloergometric evaluations.
    Jageneau A; Brugmans J
    Arzneimittelforschung; 1972 Feb; 22(2):457-9. PubMed ID: 4554634
    [No Abstract]   [Full Text] [Related]  

  • 2. Resting, exercise and postexercise heart rate and systolic time intervals in normal men treated with lidoflazine.
    De Cock W; Schuermans V; Jageneau A; De Crée J; Brugmans J
    Arzneimittelforschung; 1973 Oct; 23(10):1450-4. PubMed ID: 4591313
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lidoflazine in angina pectoris].
    Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1972 Oct; 25(5):397-403. PubMed ID: 4651962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in ECG due to lidoflazine in subjects without coronary heart disease during rest and under cycloergometric conditions].
    Lehmann HU; Scholle J; Hochrein H
    Med Welt; 1974 Sep; 25(39):1556-63. PubMed ID: 4427554
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind clinical and ECG-evaluation of lidoflazine (R 7904) in the treatment of stabilized angina pectoris.
    Keulen UW
    Curr Med Res Opin; 1973; 1(8):469-81. PubMed ID: 4589632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood circulation and ECG under the effect of propiramfumarate. Results of a double blind study].
    Kollert W; Hullmann R; Sommer J
    Arzneimittelforschung; 1974 Apr; 24(4):701-7. PubMed ID: 4599304
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease.
    Maltz MB; O'Keefe JC; Butrous GS; Camm AJ
    Arq Bras Cardiol; 1984 Jun; 42(6):443-6. PubMed ID: 6393922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Unexpected action of lidoflazine in atrial fibrillation. Preliminary report].
    Bortoluzzi DL; Rodrigues R
    Arq Bras Cardiol; 1971 Oct; 24(5):49-55. PubMed ID: 5139773
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
    Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
    Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of sildenafil on heart rate variability in healthy subjects.
    Siepmann M; Rauh R; Dill O; Agelink MW; Mueck-Weymann M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):598-600. PubMed ID: 18030072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance.
    Piessens J; De Geest H
    Cardiology; 1972; 57(3):135-49. PubMed ID: 4557527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of effort tolerance in coronary patients after Intencordin and propranolol administration].
    Adamska-Dyniewska H; Goch JH
    Pol Tyg Lek; 1973 Oct; 28(43):1683-4. PubMed ID: 4587425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.